Preterm birth, lung innate immunity, and RSV
早产、肺部先天免疫和 RSV
基本信息
- 批准号:6965619
- 负责人:
- 金额:$ 22.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-15 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:RNA interferencealveolar macrophagescell differentiationcell proliferationdefensinsdendritic cellsdisease /disorder proneness /riskgene expressiongene expression profilinggenetic susceptibilitygenetic transcriptiongestational ageimmunityimmunogeneticsnewborn animalspremature infant animalprotein quantitation /detectionpulmonary surfactantsrespiratory epitheliumrespiratory infectionsrespiratory syncytial virussheeptissue /cell culturetoll like receptor
项目摘要
DESCRIPTION (provided by the applicant): Respiratory syncytial virus (RSV) infection is the most common cause of respiratory disease leading to hospitalization in children. Preterm infants are especially susceptible to severe RSV infection. Respiratory epithelium is an initial site of RSV infection and epithelial cells along with alveolar macrophages (AM) and dendritic cells (DC) are vital to innate and adaptive immune responses. However, the extent of innate immune gene expression by epithelia and AM-DC in preterm infants can be variable/limited. The hypothesis is that: Reduced innate immunity by respiratory epithelia and AM-DC preterm enhances susceptibility to RSV infection This hypothesis is based on the facts above and our preliminary data in lambs demonstrating limited expression of surfactant proteins A and D (SP-AD), sheep beta-defensin-1 (SBD-1), and Toll-like receptor 4 (TLR4) preterm. It will be tested in preterm lambs which have close similarities with human disease including susceptibility, lesions, and innate immunity. Specific Aim 1 compares expression of key innate immune genes (SBD-1, SP-AD, TLR4) and protein/peptide production in vivo as well as AM-DC cytokine expression in pre- and full-term lung. It also tests the hypothesis that limited epithelial cell proliferation and/or differentiation pre-term underlie(s) the mechanistic basis for limited SP-AD, SDB-1 expression and tests this by comparing transcriptional activity, protein/peptide production in pre- and full term cultured cells with or without cell proliferation and differentiation. Specific Aim 2 tests the hypothesis that SP-AD, SBD-1 and AM-DC responses to RSV are less at pre- than full-term in the lamb model and in vitro with cultured epithelial cells. A second hypothesis, that increased cell proliferation and/or differentiation of epithelia protects against RSV infection, will be tested in vitro with treatments from Aim 1. The extent to which SP-AD, SBD-1 directly prevent RSV infection will be tested with RNAi assays. Specific Aim 3 tests the hypothesis that yet other innate immune genes expressed with cell proliferation/differentiation prevent RSV infection. This Aim uses gene expression profiling of primary polarized human lung cells and a respiratory epithelia-specific probe set (Unigene) that is the most well-annotated and defined gene target set to date. It also identifies ovine orthologs of human genes and test for impaired/reduced expression preterm. This team combines veterinary and human medical expertise to attain the goal of this project: to discover the reason(s) for inadequate expression of SP-AD, SBD-1 and other innate immune genes as well as AMDC responses at preterm that predispose to RSV infection. The work is significant because it discovers the underlying basis for RSV susceptibility preterm and mechanistic approaches to enhance innate immunity.
描述(由申请人提供):呼吸道合胞病毒(RSV)感染是导致儿童住院的呼吸道疾病的最常见原因。早产儿特别容易受到严重 RSV 感染。呼吸道上皮是 RSV 感染的初始部位,上皮细胞以及肺泡巨噬细胞 (AM) 和树突状细胞 (DC) 对于先天性和适应性免疫反应至关重要。然而,早产儿中上皮细胞和 AM-DC 的先天免疫基因表达程度可能是可变的/有限的。该假说是: 早产儿呼吸道上皮细胞和 AM-DC 的先天免疫力降低会增加对 RSV 感染的易感性 该假说基于上述事实以及我们在羔羊身上的初步数据,这些数据表明早产儿表面活性蛋白 A 和 D (SP-AD)、绵羊 β-防御素-1 (SBD-1) 和 Toll 样受体 4 (TLR4) 的表达有限。它将在早产羔羊身上进行测试,这些羔羊与人类疾病非常相似,包括易感性、病变和先天免疫。具体目标 1 比较了关键先天免疫基因(SBD-1、SP-AD、TLR4)的表达和体内蛋白质/肽的产生,以及足月前和足月肺中 AM-DC 细胞因子的表达。它还测试了这样的假设:足月前有限的上皮细胞增殖和/或分化是有限的 SP-AD、SDB-1 表达的机制基础,并通过比较有或没有细胞增殖和分化的足月前和足月培养细胞的转录活性、蛋白质/肽产生来测试这一点。具体目标 2 检验了以下假设:在羔羊模型中以及体外培养的上皮细胞中,SP-AD、SBD-1 和 AM-DC 对 RSV 的反应在足月前低于足月。第二个假设,即上皮细胞增殖和/或分化的增加可防止 RSV 感染,将通过目标 1 的治疗在体外进行测试。SP-AD、SBD-1 直接预防 RSV 感染的程度将通过 RNAi 测定进行测试。具体目标 3 测试了以下假设:随着细胞增殖/分化而表达的其他先天免疫基因可预防 RSV 感染。该目标使用原代极化人肺细胞的基因表达谱和呼吸道上皮特异性探针组 (Unigene),这是迄今为止注释最清楚、定义最清楚的基因靶标组。它还鉴定人类基因的绵羊直系同源物并测试早产表达受损/减少。该团队结合了兽医和人类医学专业知识来实现该项目的目标:发现 SP-AD、SBD-1 和其他先天免疫基因表达不足以及早产儿 AMDC 反应导致 RSV 感染的原因。这项工作意义重大,因为它发现了早产儿 RSV 易感性的根本基础以及增强先天免疫的机制方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark R Ackermann其他文献
Mark R Ackermann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark R Ackermann', 18)}}的其他基金
MALDI-TOF at Oregon Veterinary Diagnostic Laboratory (OVDL)
俄勒冈州兽医诊断实验室 (OVDL) 的 MALDI-TOF
- 批准号:
9905970 - 财政年份:2019
- 资助金额:
$ 22.96万 - 项目类别:
Next Generation Sequencing for Oregon Veterinary Diagnostic Laboratory
俄勒冈州兽医诊断实验室的下一代测序
- 批准号:
9906003 - 财政年份:2019
- 资助金额:
$ 22.96万 - 项目类别:
Summer Research Training for Veterinary Medical Students
兽医学生暑期研究培训
- 批准号:
8687762 - 财政年份:2013
- 资助金额:
$ 22.96万 - 项目类别:
Summer Research Training for Veterinary Medical Students
兽医学生暑期研究培训
- 批准号:
8551276 - 财政年份:2013
- 资助金额:
$ 22.96万 - 项目类别:
Antiviral properties of an oxidative host defense system of the airways
气道氧化宿主防御系统的抗病毒特性
- 批准号:
8277715 - 财政年份:2011
- 资助金额:
$ 22.96万 - 项目类别:
相似海外基金
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
- 批准号:
23K08315 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
- 批准号:
MR/X005046/1 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
- 批准号:
23H03154 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
- 批准号:
10607319 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
- 批准号:
471247 - 财政年份:2022
- 资助金额:
$ 22.96万 - 项目类别:
Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
- 批准号:
485971 - 财政年份:2022
- 资助金额:
$ 22.96万 - 项目类别:
Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
- 批准号:
22K06698 - 财政年份:2022
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
- 批准号:
462596862 - 财政年份:2021
- 资助金额:
$ 22.96万 - 项目类别:
WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
- 批准号:
21K16251 - 财政年份:2021
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
- 批准号:
NC/V001019/1 - 财政年份:2021
- 资助金额:
$ 22.96万 - 项目类别:
Research Grant














{{item.name}}会员




